Bach Multi Global Tbk. vs Brigit Biofarmaka Teknologi Tbk. — how do they compare? Bach Multi Global Tbk. trades at Rp510 (market cap 2.16T, 61.88M 24h volume), while Brigit Biofarmaka Teknologi Tbk. trades at Rp242 (market cap 164.65B, 187.4K 24h volume). The key difference: Bach Multi Global Tbk. is far larger — about 13.1× Brigit Biofarmaka Teknologi Tbk.'s market cap, and Bach Multi Global Tbk. is more actively traded (61.88M versus 187.4K). Which is the better fit depends on your goals.
| BACH | OBAT | |
|---|---|---|
Market Cap | 2.16T | 164.65B |
Volume | 61.88M | 187.4K |
Lot | 618.81K | 1.87K |
Turnover | 31.95B | 44.35M |
Average Price | 516.3 | 236.67 |
Value | 31.95B | 44.35M |
Indicative Equilibrium Price | 510 | 242 |
Indicative Equilibrium Volume | 8.62K | 500 |
Trailing returns across standard periods
Latest headlines on both assets
PT. Bach Multi Global Tbk. (the Company) was established based on Notarial Deed No. 09 of I Nyoman Rika, S.H., M.H. dated September 4, 2006. The Company started its commercial business activities in 2006.
Read more on BACH →PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Read more on OBAT →